2021 'Pharmacy +', how is the development of retail pharmacies?
The year 2020 is a year of agitation and adjustment in the retail pharmacy industry, from the O2O e-commerce that emerged in the whole "COVID-19" at the beginning of the year, to Suning, Meituan and other Internet giants layout of the pharmaceutical industry, while the postal service has been cooperating with the people's pharmacy to open pharmacies, Yixintang opened a drugstore in Hainan, many retail enterprises have made adjustments and attempts in the pharmacy business, "pharmacy + e-commerce", "pharmacy + drugstore", "pharmacy + Internet hospital", "pharmacy + convenience store", "pharmacy + medical center" and other model innovations continue to emerge, retail pharmacy development.
Because of the special nature of the retail pharmacy industry, as well as the state in the medical insurance online payment, prescription outflow has done a lot of work, coupled with the outbreak of O2O pharmaceutical e-commerce model, online pharmaceutical e-commerce model is also a major trend. The four major platforms Ali, Jingdong, Jindo and Meituan occupy the majority of the traffic entrance online, many bigwigs say they can't cooperate with these platforms, but it is impossible not to cooperate, because in the next few years, the traditional pharmacy business model determines the rise of retail pharmacies in the self-built mall and private domain traffic is difficult. Therefore, the next, "pharmacy + O2O + B2C e-commerce" will be the standard for retail pharmacies.
No matter how retail pharmacies evolve in the future, no matter how pharmacies "+", the purpose of serving customers with a human-centered approach cannot be changed, while pharmacies can also do deeper expansion in a certain area in addition to expanding the width of their operations.
Looking for chemical products? Let suppliers reach out to you!
2026-07-06
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The Production and Sales of Bivalent HPV Vaccine are Booming
-
Market Analysis - Monthly Report - November, 2020 - Pharmaceutical
-
Market Analysis - Monthly Report - November, 2020 - Oseltamivir phosphate
-
Market Analysis - Monthly Report - November, 2020 - Florfenicol
-
Market Analysis - Monthly Report - September&October, 2020 - Pharmaceutical
-
Market Analysis - Monthly Report - September&October, 2020 - Florfenicol
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
The Pill That Could Swallow the Needle: Novo Nordisk Launches Oral Wegovy in U.S. Weight-Loss Revolution
Recommend Reading
-
The $6 Billion Gold Rush: Generic Semaglutide Set to Reshape Global Pharma After Patent Cliff
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
J&J to Spin Off Orthopedics Business, Raises 2025 Forecast
-
Bayer’s Ambitious Gene & Cell Therapy Pipeline Eyes Parkinson’s, Oncology, Rare Diseases
-
Bearish Pressure Continues to Drive Down Hydrogen Peroxide Prices in China
-
Global Trade Data for Epoxy Resin in 2025 Released: Asia Accounted for $640 Million in Imports, Vietnam Emerges as Top Buyer
-
China's Acetone Market Reverses Decline and Rises
-
$15 Billion Invested in China: AstraZeneca Builds an “Innovation Hub” While Some Are Still Waiting for the Windfall
-
Weak Balance Under Cost Support—Melamine Market Struggles to Stay Firm